Does Dr. FRANCISCO ALDARONDO GARCIA have financial conflicts of interest?

Dr. FRANCISCO ALDARONDO GARCIA (MD) has received a total of $689 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $689 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. FRANCISCO ALDARONDO GARCIA?

According to CMS Open Payments data, Dr. FRANCISCO ALDARONDO GARCIA received funding from BOSTON SCIENTIFIC CORPORATION ($181), ABBOTT LABORATORIES ($135), and ASTRAZENECA PHARMACEUTICALS ($125).

Does Dr. FRANCISCO ALDARONDO GARCIA receive research grants or speaking fees?

Dr. FRANCISCO ALDARONDO GARCIA has received $689 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. FRANCISCO ALDARONDO GARCIA

MDReal-Time Hydrated

Specialty: Internal Medicine

Practice Location: BAYAMON, PR 00959

NPI Number: 1689620544

LIFETIME INDUSTRY VALUE

$689

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ALDARONDO GARCIA is a verified Internal Medicine practitioner based in BAYAMON, PR.

Between 2021 and 2025, Dr. ALDARONDO GARCIA had an overall industry promotional and research financial footprint of $689 as recorded in the federal CMS Open Payments database.

$689 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ALDARONDO GARCIA's primary funding source is BOSTON SCIENTIFIC CORPORATION, which accounts for $181 (representing 26.2% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

BOSTON SCIENTIFIC CORPORATION

Rank 1

$181

26.2%

ABBOTT LABORATORIES

Rank 2

$135

19.6%

ASTRAZENECA PHARMACEUTICALS

Rank 3

$125

18.1%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.